Physiologie de l’Axe Gonadotrope (ERL U1133 INSERM)

 

 

Sélection de publications

1/ Simon V, Avet C, Grange-Messent V, Wargnier R, Denoyelle C, Pierre A, Dairou J, Dupret JM, Cohen-Tannoudji J. Carbon Black Nanoparticles Inhibit Aromatase Expression and Estradiol Secretion in Human Granulosa Cells Through the ERK1/2 Pathway. Endocrinology. 2017 Oct 1;158(10):3200-3211.

2/ Lannes J, L’hôte D, Fernandez-Vega A, Garrel G, Laverrière JN, Cohen-Tannoudji J, Quérat B. A regulatory loop between miR-132 and miR-1 125b involved in gonadotrope cells desensitization to GnRH. Sci. Rep. 2016 Aug 19;6:31563. (Abstract) http://www.cnrs.fr/insb/recherche/parutions/articles2016/b-querat.html

3/ Garrel G, Racine C, L’Hôte D, Denoyelle C, Guigon CJ, di Clemente N, Cohen-Tannoudji J. Anti-Müllerian hormone: a new actor of sexual dimorphism in pituitary gonadotrope activity before puberty. Sci Rep. 2016 Mar 31;6:23790. (Abstract) http://www.sfendocrino.org/_newsletters/345.html

4/ François CM, Wargnier R, Petit F, Goulvent T, Rimokh R, Treilleux I, Ray-Coquard I, Zazzu V, Cohen-Tannoudji J, Guigon CJ. 17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1. Carcinogenesis. 2015 May;36(5):564-73. (Abstract)

5/ Vandormael-Pournin S, Guigon CJ, Ishaq M, Coudouel N, Avé P, Huerre M, Magre S, Cohen-Tannoudji J, Cohen-Tannoudji M. Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells. Cell Death Differ. 2015 Jan;22(1):108-17. (Abstract) http://www.cnrs.fr/insb/recherche/parutions/articles2014/m-cohen.html

 

Publications indexées dans PubMed (depuis 2014)

 

Devillers M, Petit F, Cluzet V, François CM, Giton F, Garrel G, Cohen-Tannoudji J, Guigon CJ. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice. J Endocrinol. 2018 Nov.

Garrel G, Denoyelle C, L’Hôte D, Picard JY, Teixeira J, Kaiser UB, Laverrière JN, Cohen-Tannoudji J. GnRH transactivates human AMH receptor gene via Egr1 and FOXO1 in gonadotrope cells. Neuroendocrinology. 2018 Oct 28.

Avet C, Denoyelle C, L’Hôte D, Petit F, Guigon CJ, Cohen-Tannoudji J, Simon V. GnRH regulates the expression of its receptor accessory protein SET in pituitary gonadotropes. PLoS One. 2018 Jul 27;13(7):e0201494.

Fouquet B, Pawlikowska P, Caburet S, Guigon C, Mäkinen M, Tanner L, Hietala M, Urbanska K, Bellutti L, Legois B, Bessieres B, Gougeon A, Benachi A, Livera G, Rosselli F, Veitia RA, Misrahi M. A homozygous FANCM mutation underlies a familial case of non-syndromic primary ovarian insufficiency. Elife. 2017 Dec 12;6. pii: e30490.

Penrad-Mobayed M, Perrin C, L’Hôte D, Contremoulins V, Lepesant JA, Boizet-Bonhoure B, Poulat F, Baudin X, Veitia RA. A role for SOX9 in post-transcriptional processes: insights from the amphibian oocyte. Sci Rep. 2018 May 8;8(1):7191.

Pierre A, Taieb J, Giton F, Grynberg M, Touleimat S, El Hachem H, Fanchin R, Monniaux D, Cohen-Tannoudji J, di Clemente N, Racine C. Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017 Nov 1;102(11):3970-3978.

Simon V, Avet C, Grange-Messent V, Wargnier R, Denoyelle C, Pierre A, Dairou J, Dupret JM, Cohen-Tannoudji J. Carbon Black Nanoparticles Inhibit Aromatase Expression and Estradiol Secretion in Human Granulosa Cells Through the ERK1/2 Pathway. Endocrinology. 2017 Oct 1;158(10):3200-3211.

Ayrout M, Simon V, Bernard V, Binart N, Cohen-Tannoudji J, Lombès M, Chauvin S. A novel non genomic glucocorticoid signaling mediated by a membrane palmitoylated glucocorticoid receptor cross talks with GnRH in gonadotrope cells. Sci Rep. 2017 May 8;7(1):1537.

François CM, Petit F, Giton F, Gougeon A, Ravel C, Magre S, Cohen-Tannoudji J, Guigon CJ. A novel action of follicle-stimulating hormone in the ovary promotes estradiol production without inducing excessive follicular growth before puberty. Sci Rep. 2017 Apr 11;7:46222.

Lannes J, L’Hôte D, Fernandez-Vega A, Garrel G, Laverrière JN, Cohen-Tannoudji J, Quérat B. [microRNA and inactivation of the pituitary gonadotrope function]. Med Sci (Paris). 2017 Apr;33(4):386-388.

Garrel G, Racine C, L’Hôte D, Denoyelle C, Guigon CJ, di Clemente N, Cohen-Tannoudji J. [Anti-Müllerian hormone: a new regulator of pituitary gonadotrope cells. Involvement in sexual dimorphism of gonadotrope activity before puberty]. Med Sci (Paris). 2016 Dec;32(12):1076-1078.

Lannes J, L’hôte D, Fernandez-Vega A, Garrel G, Laverrière JN, Cohen-Tannoudji J, Quérat B. Corrigendum: A regulatory loop between miR-132 and miR-125b involved in gonadotrope cells desensitization to GnRH. Sci Rep. 2016 Oct 5;6:34676.

Garrel G, Racine C, L’Hôte D, Denoyelle C, Guigon CJ, di Clemente N, Cohen-Tannoudji J. Anti-Müllerian hormone: a new actor of sexual dimorphism in pituitary gonadotrope activity before puberty. Sci Rep. 2016 Mar 31;6:23790.

Pierre A, Estienne A, Racine C, Picard JY, Fanchin R, Lahoz B, Alabart JL, Folch J, Jarrier P, Fabre S, Monniaux D, di Clemente N. The Bone Morphogenetic Protein 15 Up-Regulates the Anti-Müllerian Hormone Receptor Expression in Granulosa Cells. J Clin Endocrinol Metab. 2016 Jun;101(6):2602-11.

Lannes J, L’Hôte D, Fernandez-Vega A, Garrel G, Laverrière JN, Cohen-Tannoudji J, Quérat B. A regulatory loop between miR-132 and miR-1 125b involved in gonadotrope cells desensitization to GnRH. Sci. Rep. 2016 Aug 19;6:31563.

Laverrière JN, L’Hôte D, Tabouy L, Schang AL, Quérat B, Cohen-Tannoudji J. Epigenetic regulation of alternative promoters and enhancers in progenitor, immature, and mature gonadotrope cell lines. Mol Cell. Endocrinol. 2016 Oct;15;434:250-65.

Pierre A, Racine C, Rey R, Fanchin R, Taieb J, Cohen-Tannoudji J, Carmillo P, Pepinsky B, Cate RL, di Clemente N. Most cleaved anti-Müllerian hormone binds its receptor in human follicular fluid, but little is competent in serum. J Clin Endocr Metab. 2016 Sept 13.

Estienne A, Pierre A, di Clemente N, Picard JY, Jarrier P, Mansanet C, Monniaux D, Fabre S. Anti-Müllerian hormone regulation by the bone morphogenetic proteins in the sheep ovary: deciphering a direct regulatory pathway. Endocrinology. 2015 Jan;156(1):301-13.

Vandormael-Pournin S, Guigon CJ, Ishaq M, Coudouel N, Avé P, Huerre M, Magre S, Cohen-Tannoudji J, Cohen-Tannoudji M. Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells. Cell Death Differ. 2015 Jan;22(1):108-17.

Lannes J, L’Hôte D, Garrel G, Laverrière JN, Cohen-Tannoudji J, Quérat B. A MicroRNA-132/212 Pathway Mediates GnRH Activation of FSH Expression. Mol Endocrinol. 2015 Mar;29(3):364-72.

Palandri A, L’Hôte D, Cohen-Tannoudji J, Tricoire H, Monnier V. Frataxin inactivation leads to steroid deficiency in flies and human ovarian cells. Hum Mol Genet. 2015 May 1;24(9):2615-26.

François CM, Wargnier R, Petit F, Goulvent T, Rimokh R, Treilleux I, Ray-Coquard I, Zazzu V, Cohen-Tannoudji J, Guigon CJ. 17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1. Carcinogenesis. 2015 May;36(5):564-73.

Manna PR, Stetson CL, Daugherty C, Shimizu I, Syapin PJ, Garrel G, Cohen-Tannoudji J, Huhtaniemi I, Slominski AT, Pruitt K, Stocco DM. Up-regulation of steroid biosynthesis by retinoid signaling: Implications for aging. Mech Ageing Dev. 2015 Sep;150:74-82.

Hirschhorn T, di Clemente N, Amsalem AR, Pepinsky RB, Picard JY, Smorodinsky NI, Cate RL, Ehrlich M. Constitutive negative regulation in the processing of the anti-Müllerian hormone receptor II. J Cell Sci. 2015 Apr 1;128(7):1352-64.

Arouche N, Picard JY, Monniaux D, Jamin SP, Vigier B, Josso N, Cate RL, di Clemente N, Taieb J. The BOC ELISA, a ruminant-specific AMH immunoassay, improves the determination of plasma AMH concentration and its correlation with embryo production in cattle. Theriogenology. 2015 Nov;84(8):1397-404.

El Hadri K, Denoyelle C, Ravaux L, Viollet B, Foretz M, Friguet B, Rouis M, Raymondjean M. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs. PLoS One. 2015 Jul 10;10(7):e0132498.

Shinomura M, Kishi K, Tomita A, Kawasumi M, Kanezashi H, Kuroda Y, Tsunekawa N, Ozawa A, Aiyama Y, Yoneda A, Suzuki H, Saito M, Picard JY, Kohno K, Kurohmaru M, Kanai-Azuma M, Kanai Y. A novel Amh-Treck transgenic mouse line allows toxin-dependent loss of supporting cells in gonads. Reproduction. 2014 Dec;148(6):H1-9.

Anttonen M, Pihlajoki M, Andersson N, Georges A, L’Hôte D, Vattulainen S, Färkkilä A, Unkila-Kallio L, Veitia RA, Heikinheimo M. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells. PLoS One. 2014 Jan 9;9(1):e85545.

Georges A, L’Hôte D, Todeschini AL, Auguste A, Legois B, Zider A, Veitia RA. The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells. eLife. 2014 Nov 4;3.

Pasquier J, Lafont AG, Rousseau K, Quérat B, Chemineau P, Dufour S. Looking for the bird Kiss: evolutionary scenario in sauropsids. BMC Evol Biol. 2014 Feb 19;14(1):30.

Garrel G, Simon V, Denoyelle C, Ishaq M, Rouch C, Dairou J, Magnan C, Migrenne S, Cruciani-Guglielmacci C, Cohen-Tannoudji J. Unsaturated fatty acids disrupt Smad signaling in gonadotrope cells leading to inhibition of FSHβ gene expression. Endocrinology. 2014 Feb;155(2):592-604.

Maugars G, Dufour S, Cohen-Tannoudji J, Quérat B. Multiple thyrotropin β-subunit and thyrotropin receptor-related genes arose during vertebrate evolution. PLoS One. 2014 Nov 11;9(11):e111361.

 

Etudes cliniques (INSERM U1133)

Victoria M, Labrosse J, Krief F, Cédrin-Durnerin I, Comtet M, Grynberg M. Anti Müllerian Hormone: more than a biomarker of female reproductive function. J Gynecol Obstet Hum Reprod. 2018 Oct 20. pii: S2468-7847(18)30406-9.

Papanikolaou EG, Timotheou E, Tatsi P, Janssens H, Grynberg M, Athanasiadis A, Zafeirati C, Najdecki R, Petousis S. COMFFETI, Combined Fresh and Frozen Embryo Transfers per Individual: A New Index of Quality Control for The Performance of emberyologic Labs in The Emerging Era of Segmentation of Cycle and Freeze-All Strategy. Int J Fertil Steril. 2019 Jan;12(4):339-342.

Pistilli B, Mazouni C, Zingarello A, Faron M, Saghatchian M, Grynberg M, Spielmann M, Kerbrat P, Roché H, Lorgis V, Bachelot T, Campone M, Levy C, Gonçalves A, Lesur A, Veyret C, Vanlemmens L, Lemonnier J, Delaloge S. Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials. Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30264-7.

Sonigo C, Jankowski S, Yoo O, Trassard O, Bousquet N, Grynberg M, Beau I, Binart N. High-throughput ovarian follicle counting by an innovative deep learning approach. Sci Rep. 2018 Sep 10;8(1):13499.

Sonigo C, Beau I, Grynberg M, Binart N. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J. 2018 Aug 16:fj201801089R.

Scheffer JAB, Scheffer B, Scheffer R, Florencio F, Grynberg M, Lozano DM. Are  age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF? JBRA Assist Reprod. 2018 Sep 1;22(3):215-220.

Bénard J, Sermondade N, Grynberg M. Fertility Preservation in Endocrine Disorders during Transition for Girls. Endocr Dev. 2018;33:128-148.

Vinolas C, Raad J, Sonigo C, Sifer C, Sermondade N, Grynberg M. Medical techniques of fertility preservation in the male and female. J Visc Surg. 2018 Jun;155 Suppl 1:S3-S9.

Papanikolaou EG, Yarali H, Timotheou E, Grynberg M, Zafeiratis O, Tournaye H, Najdecki R. A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol. Front Endocrinol (Lausanne). 2018 Mar 1;9:25.

Grynberg M. The challenges of fertility preservation in cancer patients: an interview with Michael Grynberg. Future Oncol. 2018 Mar;14(6):497-498.

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]. Bull Cancer. 2018 Mar;105(3):299-314.

Grynberg M, Sonigo C, Santulli P. Fertility Preservation in Women. N Engl J Med. 2018 Jan 25;378(4):400.

Grynberg M, Raad J, Comtet M, Vinolas C, Cédrin-Durnerin I, Sonigo C. Fertility preservation in BRCA-mutated women: when and how? Future Oncol. 2018 Feb;14(5):483-490.

Raad J, Sonigo C, Tran C, Sifer C, Durnerin IC, Grynberg M. Oocyte vitrification for preserving fertility in patients with endometriosis: first observational cohort study… and many unresolved questions. Letter to the Editor.  Eur J Obstet Gynecol Reprod Biol. 2018 Jan;220:140-141.

Sonigo C, Comtet M, Duros S, Sifer C, Sermondade N, Grynberg M. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin’s lymphoma when compared with breast cancer candidates for fertility preservation. J Assist Reprod Genet. 2018 Jan;35(1):91-97.

Herbemont C, Sarandi S, Boujenah J, Cedrin-Durnerin I, Sermondade N, Vivot A, Poncelet C, Grynberg M, Sifer C. Should we consider day-2 and day-3 embryo morphology before day-5 transfer when blastocysts reach a similar good quality? Reprod Biomed Online. 2017 Nov;35(5):521-528.

Albarracín FAG, Rosales HD, Grynberg MD. Phase ordering dynamics of reconstituting particles. Phys Rev E. 2017 Jun;95(6-1):062130.

Hugon-Rodin J, Sonigo C, Drummond D, Grynberg M, Rodin T, Plu-Bureau G, Tesniere A. [Learning the gynecological examination on low-fidelity simulation: Impact on the feelings of medical students]. Gynecol Obstet Fertil Senol. 2017 May;45(5):291-298.

Hugon-Rodin J, Sonigo C, Gompel A, Dodé C, Grynberg M, Binart N, Beau I. First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome. BMC Med Genet. 2017 Apr 26;18(1):44.

Scheffer JB, Scheffer BB, de Carvalho RF, Rodrigues J, Grynberg M, Mendez Lozano DH. Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response. Int J Fertil Steril. 2017 Apr-Jun;11(1):40-46.

Gronier H, Sonigo C, Bringer S, Cedrin-Durnerin I, Hugues JN, Grynberg M. [Does accumulation of oocytes benefit to women with poor ovarian reserve? No]. Gynecol Obstet Fertil Senol. 2017 Mar;45(3):183-184.

Carde PP, Grynberg M, Poirot C, Glimelius B, Mounier N. Reply to C.F. Hess et al. J Clin Oncol. 2017 Jan 20;35(3):374.

Sonigo C, Sermondade N, Grynberg M. Letter in reply to « Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations ». Future Oncol. 2017 Mar;13(7):591-592.

Grynberg M, Parker J, Dennis-Beron S. The challenge of fertility preservation in cancer patients II: a themed issue of Future Oncology. Future Oncol. 2016 Oct;12(20):2291-2.

Sifer C, Sellam-Chokron O, Sermondade N, Cedrin-Durnerin I, Sonigo C, Herbemont C, Grynberg M. Should metaphase 1 and 2 stages oocytes be vitrified in  the same time for fertility preservation? Future Oncol. 2016 Oct;12(20):2297-305.

Grynberg M. The challenge of fertility preservation in cancer patients: a special focus issue from Future Oncology. Future Oncol. 2016 Jul;12(14):1667-9.

Bénard J, Duros S, El Hachem H, Sonigo C, Sifer C, Grynberg M. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients:  the state of the art. Future Oncol. 2016 Jul;12(14):1731-41.

Bénard J, Duros S, Hachem HE, Sonigo C, Sifer C, Grynberg M. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art. Future Oncol. 2016 May 17.

Sonigo C, Simon C, Boubaya M, Benoit A, Sifer C, Sermondade N, Grynberg M. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? Hum Reprod. 2016 Jul;31(7):1493-500.

Bénard J, Calvo J, Comtet M, Benoit A, Sifer C, Grynberg M. [Fertility preservation in women of the childbearing age: Indications and strategies]. J Gynecol Obstet Biol Reprod (Paris). 2016 May;45(5):424-44. Review. French.

Sarandi S, Herbemont C, Sermondade N, Benoit A, Sonigo C, Poncelet C, Benard J, Gronier H, Boujenah J, Grynberg M, Sifer C. [A prospective study to compare the efficiency of oocyte vitrification using closed or open devices]. Gynecol Obstet Fertil. 2016 May;44(5):280-4. French.

Sonigo C, Seroka A, Cédrin-Durnerin I, Sermondade N, Sifer C, Grynberg M. History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates. Future Oncol. 2016 Mar 10.

Valdelièvre C, Sonigo C, Comtet M, Simon C, Eskenazi S, Grynberg M. [Impact of gonadotropins in women suffering from cancer]. Bull Cancer. 2016 Mar;103(3):282-8. Review. French.

Durand M, Sermondade N, Herbemont C, Benard J, Gronier H, Boujenah J, Cédrin-Durnerin I, Poncelet C, Grynberg M, Sifer C. [Embryo development in two single-step media: Analysis of 2059 sibling oocytes]. Gynecol Obstet Fertil. 2016 Mar;44(3):163-7. French.

Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Hum Reprod. 2016 Mar;31(3):623-9.

Frydman R, Grynberg M. Introduction: Male fertility preservation: innovations and questions. Fertil Steril. 2016 Feb;105(2):247-8.

Grynberg M, Bidet M, Benard J, Poulain M, Sonigo C, Cédrin-Durnerin I, Polak M. Fertility preservation in Turner syndrome. Fertil Steril. 2016 Jan;105(1):13-9.

Grynberg M, Benard J. [Fertility preservation and endometriosis: When medical borders on social]. Gynecol Obstet Fertil. 2015 Dec;43(12):759-60. French.

Comtet M, Sonigo C, Valdelièvre C, Sermondade N, Sifer C, Grynberg M. [Fertility preservation in breast cancer patients: the state of art in 2014?]. Bull Cancer. 2015 May;102(5):443-53. Review. French.

Sonigo C, Sermondade N, Benard J, Benoit A, Shore J, Sifer C, Grynberg M. The past, present and future of fertility preservation in cancer patients. Future Oncol. 2015 Sep 11.

Sebag-Peyrelevade S, El Hachem H, Gallot V, Genro VK, Fanchin R. [The influence of exogenous LH/hCG activity on serum progesterone levels on the day of hCG administration in in vitro fertilization]. J Gynecol Obstet Biol Reprod (Paris). 2015 Jun;44(6):524-31. French.

Dupont C, Hafhouf E, Sermondade N, Sellam O, Herbemont C, Boujenah J, Faure C, Levy R, Poncelet C, Hugues JN, Cedrin-Durnerin I, Sonigo C, Grynberg M, Sifer C. Delivery rates after elective single cryopreserved embryo transfer related to embryo survival. Eur J Obstet Gynecol Reprod Biol. 2015 Feb 26;188:6-11.

Grynberg M. A plea for female fertility preservation. Future Oncol. 2014 Nov;10(14):2107-10.

El Hachem H, Atallah D, Grynberg M. Fertility preservation in breast cancer patients. Future Oncol. 2014 Aug;10(10):1767-77.

Sifer C, Herbemont C, Adda-Herzog E, Sermondade N, Dupont C, Cedrin-Durnerin I, Poncelet C, Levy R, Grynberg M, Hugues JN. Clinical predictive criteria associated with live birth following elective single embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:229-32.

Sifer C, Khattabi LE, Dupont C, Sermondade N, Herbemont C, Porcher R, Cedrin-Durnerin I, Faure C, Lévy R, Grynberg M, Poncelet C, Hugues JN. Could sperm grade under high magnification condition predict IMSI clinical outcome? Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:189-94.

Foix-L’Hélias L, Grynberg M, Ducot B, Frydman N, Kerbrat V, Bouyer J, Labrune P. Growth development of French children born after in vitro maturation. PLoS One. 2014 Feb 26;9(2):e89713.

Hachem HE, Poulain M, Höher M, Fanchin R, Frydman R, Grynberg M. Serous adenocarcinoma of the ovary diagnosed during ultrasound evaluation for fertility preservation. Future Oncol. 2014 Oct;10(12):1907-12.

Legendre G, Moulin J, Vialard J, Ziegler DD, Fanchin R, Pouly JL, Watrelot A, Belaisch Allart J, Massin N, Fernandez H. Proximal occlusion of hydrosalpinges by Essure(®) before assisted reproduction techniques: a French survey. Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:300-4.

Trèves R, Grynberg M, Parco Sl, Finet A, Poulain M, Fanchin R. Female fertility preservation in cancer patients: an instrumental tool for the envisioning a postdisease life. Future Oncol. 2014 May;10(6):969-74.

Poulain M, Hesters L, Sanglier T, de Bantel A, Fanchin R, Frydman N, Grynberg M. Is it acceptable to destroy or include human embryos before day 5 in research programmes? Reprod Biomed Online. 2014 Apr;28(4):522-9.

El Hachem H, Poulain M, Finet A, Fanchin R, Frydman N, Grynberg MH. Live birth after frozen-thawed oocytes matured in vitro in a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes matured in vitro. Gynecol Endocrinol. 2014 Jun;30(6):415-8.

Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C, Mason H, Nelson SM, Visser JA, Wallace WH, Anderson RA. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014 May-Jun;20(3):370-85.

Steffann J, Gigarel N, Samuels DC, Monnot S, Borghese R, Hesters L, Frydman N, Burlet P, Frydman R, Benachi A, Rotig A, Munnich A, Bonnefont JP. Data from artificial models of mitochondrial DNA disorders are not always applicable to humans. Cell Rep. 2014 May 22;7(4):933-4.